FAKTOR OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Delayed Deutsche Boerse AG 07:21:20 2024-07-11 am EDT | ||
| 0.94 EUR | 0.00% |
|
| Current month | +2.17% | ||
| 1 month | +34.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 0.94 | 0.00% |
| 24-07-10 | 0.94 | +1.08% |
| 24-07-09 | 0.93 | +6.90% |
| 24-07-08 | 0.87 | -2.25% |
| 24-07-05 | 0.89 | +5.95% |
Delayed Quote Deutsche Boerse AG
Last update July 11, 2024 at 07:21 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PN4EDW |
| ISIN | DE000PN4EDW7 |
| Date issued | 2021-11-09 |
| Strike | 93.78 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 30 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 40.77 € |
|---|---|
| Lowest since issue | 0.27 € |
| Spread | 0.03 € |
| Spread % | 3.09% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
93.78
USD
Average target price
96.16
USD
Spread / Average Target
+2.54%
- Stock Market
- Certificates
- Certificat
